Vivos Inc.
RDGL
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$0.09
FAIR PRICE
$0.05
MARGIN
$0.04
P/E Ratio
N/A
Div. Yield
N/A
ROE
-118.1%
Market Cap
$40M
Small-cap
COMING SOON
Get notified when RDGL's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Michael K. Korenko
COUNTRY
US
HEADQUARTERS
Kennewick
SECTOR
Healthcare
EXCHANGE
OTC
METHODOLOGY
How we calculate RDGL's fair price
Vivos Inc.'s fair price of $0.05 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $0.09, RDGL trades 42.3% above its calculated fair value.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting RDGL's risk profile.
RELATIVE · 30%
Comparing RDGL's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for RDGL, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for RDGL.
Explore on BuliosFAQ
What is the fair price of RDGL?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Vivos Inc. is $0.05. At the current market price of $0.09, RDGL trades 42.3% above its calculated fair value.
Is RDGL overvalued or undervalued?+
Vivos Inc. is currently overvalued based on our valuation model. The stock trades at $0.09, which is 42.3% above the fair price of $0.05.
How often is RDGL's fair price updated?+
We update fair price calculations for RDGL daily after market close. The current fair price of $0.05 incorporates the latest market data and sector multiples.
What factors affect RDGL's fair price calculation?+
RDGL's fair price of $0.05 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -118.1%.
Is RDGL a good buy right now?+
At $0.09, RDGL trades 42.3% above our fair value estimate of $0.05. The stock is currently overvalued. ROE stands at -118.1% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does RDGL pay dividends?+
RDGL does not currently pay a dividend.